Treatment with TransCon CNP demonstrated continued improvement in observed change from baseline in upper-to-lower body segment ratio during the second year, from -0.04 at Week 52 to -0.10 at Week 104.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results